What does Dr. Sara Vansina, Dermatologie do?

Dr. Sara Vansina, Dermatologie is a specialist medical practice in Leuven. Private Limited, started on 11 October 2016, 1 establishment.

What is the address of Dr. Sara Vansina, Dermatologie?

The registered office of Dr. Sara Vansina, Dermatologie is located at Weggevoerdenstraat 59, 3012 Leuven.

Is Dr. Sara Vansina, Dermatologie still active?

Yes. According to the CBE (1 October 2026) Dr. Sara Vansina, Dermatologie is active, legal situation “Normale toestand”, started on 11 October 2016.

Is Dr. Sara Vansina, Dermatologie registered on Peppol?

Yes, Dr. Sara Vansina, Dermatologie is registered on the Peppol network with ID 0208:0664528390.

What is the enterprise number of Dr. Sara Vansina, Dermatologie?

The enterprise number of Dr. Sara Vansina, Dermatologie is BE0664528390.

When was Dr. Sara Vansina, Dermatologie founded?

Dr. Sara Vansina, Dermatologie was founded on 11 October 2016.

Who are the directors of Dr. Sara Vansina, Dermatologie?

According to the 2025 annual accounts, the directors of Dr. Sara Vansina, Dermatologie are: Sara Gabrielle Vansina.

Is Dr. Sara Vansina, Dermatologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 October 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Sara Vansina, Dermatologie make in 2025?

Dr. Sara Vansina, Dermatologie posted a profit after taxes of € 93,583 in financial year 2025.

What is the revenue of Dr. Sara Vansina, Dermatologie?

As a small company, Dr. Sara Vansina, Dermatologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 124,117.

Dr. Sara Vansina, Dermatologie (Private Limited) - Leuven

Dossier Dr. Sara Vansina, Dermatologie, printed on 1 October 2026 from databakkes.be/en/0664528390/dr-sara-vansina-dermatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Sara Vansina, Dermatologie from Leuven, company number BE0664528390, closed financial year 2025 with a result of € 93,583 after tax. For that financial year Dr. Sara Vansina, Dermatologie recorded a gross margin of € 124,117 and equity of € 18,600. Compared with financial year 2024, the result moved from € 87,331 to € 93,583. Profitable, and profit is growing. The buffer shrank hard: equity is 82 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Shrank hard

€ 18,600

▼ 82% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 93,583

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 119,777

▼ 38% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 180,913 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,720

▼ 44% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,316

▼ 89% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,037

▲ € 12,870 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 95,099 Gross margin 2022: € 95,099 First fiscal year in the series	€ 126,573 Gross margin 2023: € 126,573 ▲ 33% vs 2022 (€ 95,099) Favourable step	€ 120,781 Gross margin 2024: € 120,781 ▼ 5% vs 2023 (€ 126,573) Unfavourable step	€ 124,117 Gross margin 2025: € 124,117 ▲ 3% vs 2024 (€ 120,781) Favourable step	▲ 3%
Profit after taxes	€ 72,984 Profit after taxes 2022: € 72,984 First fiscal year in the series	€ 95,221 Profit after taxes 2023: € 95,221 ▲ 30% vs 2022 (€ 72,984) Favourable step	€ 87,331 Profit after taxes 2024: € 87,331 ▼ 8% vs 2023 (€ 95,221) Unfavourable step	€ 93,583 Profit after taxes 2025: € 93,583 ▲ 7% vs 2024 (€ 87,331) Favourable step	▲ 7%
Equity	€ 203,341 Equity 2022: € 203,341 First fiscal year in the series	€ 191,562 Equity 2023: € 191,562 ▼ 6% vs 2022 (€ 203,341) Unfavourable step	€ 105,931 Equity 2024: € 105,931 ▼ 45% vs 2023 (€ 191,562) Unfavourable step	€ 18,600 Equity 2025: € 18,600 ▼ 82% vs 2024 (€ 105,931) Unfavourable step	▼ 82%
Total debts	€ 44,807 Total debts 2022: € 44,807 First fiscal year in the series	€ 56,273 Total debts 2023: € 56,273 ▲ 26% vs 2022 (€ 44,807) Unfavourable step	€ 215,140 Total debts 2024: € 215,140 ▲ 282% vs 2023 (€ 56,273) Unfavourable step	€ 297,366 Total debts 2025: € 297,366 ▲ 38% vs 2024 (€ 215,140) Unfavourable step	▲ 38%
Cash	€ 237,603 Cash 2022: € 237,603 First fiscal year in the series	€ 225,135 Cash 2023: € 225,135 ▼ 5% vs 2022 (€ 237,603) Unfavourable step	€ 194,012 Cash 2024: € 194,012 ▼ 14% vs 2023 (€ 225,135) Unfavourable step	€ 119,777 Cash 2025: € 119,777 ▼ 38% vs 2024 (€ 194,012) Unfavourable step	▼ 38%
Retained profit	€ 184,741 Retained profit 2022: € 184,741 First fiscal year in the series	€ 172,962 Retained profit 2023: € 172,962 ▼ 6% vs 2022 (€ 184,741) Unfavourable step	€ 87,331 Retained profit 2024: € 87,331 ▼ 50% vs 2023 (€ 172,962) Unfavourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 87,331) Unfavourable step	▼ 100%
Dividend	€ 183,000 Dividend 2022: € 183,000 First fiscal year in the series	€ 107,000 Dividend 2023: € 107,000 ▼ 42% vs 2022 (€ 183,000) Unchanged	€ 172,962 Dividend 2024: € 172,962 ▲ 62% vs 2023 (€ 107,000) Unchanged	€ 180,913 Dividend 2025: € 180,913 ▲ 5% vs 2024 (€ 172,962) Unchanged	▲ 5%
Balance sheet total	€ 248,148 Balance sheet total 2022: € 248,148 First fiscal year in the series	€ 247,835 Balance sheet total 2023: € 247,835 Unchanged (€ 248,148) Unchanged	€ 321,071 Balance sheet total 2024: € 321,071 ▲ 30% vs 2023 (€ 247,835) Unchanged	€ 315,966 Balance sheet total 2025: € 315,966 ▼ 2% vs 2024 (€ 321,071) Unchanged	▼ 2%

Key figures of Dr. Sara Vansina, Dermatologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Sara Vansina, Dermatologie?

What happened at Dr. Sara Vansina, Dermatologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 93,583 (▲ 7% vs 2024). Source: NBB ↗
Oct 11, 2016 New establishment in Leuven. KBO
2016 Sara Gabrielle Vansina became a director. NBB
Oct 11, 2016 Start of the company according to the CBE. KBO

In short

From € 72,984 profit in 2022 to € 93,583 profit in 2025.

Paid € 96,721 in corporate taxes since 2022.

Best year ever: 2023, with € 95,221 profit.

Paid out € 643,875 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Sara Vansina, Dermatologie? We notify you, reason included.

Follow Dr. Sara Vansina, Dermatologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sara Gabrielle Vansina

Dr. Sara Vansina, Dermatologie

RemyDerm

Behind Dr. Sara Vansina, Dermatologie is Sara Gabrielle Vansina. Sara Gabrielle Vansina is also behind RemyDerm.

See the full network in the app

Directors

According to the 2025 annual accounts

Sara Gabrielle Vansina

Director

Also active at: RemyDerm

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Weggevoerdenstraat 59

3012 Leuven

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0664.528.390
VAT number: BE 0664.528.390
Registered office: Weggevoerdenstraat 59, 3012 Leuven
Names & denominations: Dr. Sara Vansina, Dermatologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 11 October 2016
Peppol: Active · Active since 3 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗